Sources before spectacle.

Independence and identity

Daily Elon Musk is not affiliated with, endorsed by, funded by or operated by Elon Musk, Tesla, SpaceX, xAI, Neuralink, X, The Boring Company or their affiliates. The name describes the publication's editorial subject. We do not use company logos or presentation that suggests an official relationship.

Evidence labels

Official

The claim comes from a company newsroom, regulator, court filing, government agency, published study or an attributable first-party statement. “Official” identifies the origin; it does not mean the claim has been independently verified.

Reported

The claim comes from a named news organization or journalist. We link to the report and attribute material claims.

Developing

Reliable information exists, but key facts may still change. We update the item as stronger evidence becomes available.

Sourcing and rights

Every factual brief should link to its primary or original reporting source. We write original headlines, summaries and analysis. We do not republish complete articles, paywalled text, private material or images without appropriate rights. Live Wire is an automated headline index that sends readers to the originating publisher.

Automation and AI

Automation may collect public headlines, identify duplicates, organize source queues or assist with drafting. Automation does not convert an unverified claim into a verified fact. Editorial posts require source review before publication. AI-assisted language is checked for attribution, dates, numbers and unsupported certainty.

Corrections and updates

Material factual errors are corrected promptly. A correction should state what changed when the change affects a reader's understanding. Minor spelling or formatting fixes may be made without a note. Send a correction request with the URL, disputed text and supporting source to editor@dailyelonmusk.com.

Editorial boundaries

• Advertising is labeled and does not purchase favorable coverage.
• Investment-related coverage is information, not individualized financial advice.
• Medical and clinical-trial coverage is information, not diagnosis or treatment advice.
• Opinion and analysis should be labeled and separated from factual updates.
• We avoid private personal details that lack a clear public-interest reason.

Readers should use original filings, regulators, trial registries and qualified professionals for decisions with financial, legal or medical consequences.